Sana Biotechnology SANA Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's other income, net (note 6)?
- Sana Biotechnology (SANA) reported other income, net (note 6) of $453K in Q1 2026.
- How has Sana Biotechnology's other income, net (note 6) changed year-over-year?
- Sana Biotechnology's other income, net (note 6) increased by 81.9% year-over-year, from $249K to $453K.
- What is the long-term trend for Sana Biotechnology's other income, net (note 6)?
- Over 4 years (2021 to 2025), Sana Biotechnology's other income, net (note 6) has grown at a 65.8% compound annual growth rate (CAGR), from $305K to $2.31M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.